Livanova Plc (LIVN) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Livanova Plc  (NASDAQ: LIVN)


Livanova Plc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Livanova Plc's ROI in the third quarter of 2026?
Livanova Plc achieved a return on average invested assets (ROI) of 10.51 % in its third quarter of 2026, this is above LIVN's average return on investment of -3.32%.
Livanova Plc invested over the 12 months ending in its third quarter of 2026 $1,865 million

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2026.

Within the Healthcare sector 80 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1379, from total ROI ranking in the second quarter of 2026 at 1962.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -3.53 % -12 % -11.19 % -13.71 % -9.82 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,973 1,934 1,754 1,798 1,730
Return On Investment (TTM) 10.51 % 10.45 % 5.83 % -13.08 % -11.25 %
LIVN's Overall Ranking # 1379 # 1962 # 2862 # 2692 #
Seq. Investment Change TTM 3.37 % -1.86 % -0.85 % -4.09 % -5.7 %
Seq. Net Income Change TTM 3.98 % 75.98 % - - -
Net Income (TTM) in Millions 196 189 107 -242 -217

LIVN Company Profile >> Back to LIVN Roi Comparisons >> See Annual LIVN Return On Investment



Return On Investment LIVN's Ranking
Within: No.
Industry # 26
Sector # 81
Overall # 1379

Return On Investment Statistics
High Average Low
29.73 %
-3.32 %
-21.89 %
(Apr 24 2015)   (Sep 30 2021)







Financial Statements
Livanova Plc's III. Quarter Investments $ 1,973 Millions LIVN's Balance sheet
Livanova Plc's III. Quarter Income $ 34 Millions Quarterly LIVN's Income Statement
LIVN's Income by Division See LIVN's Income by Division


LIVN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,798 2,114 2,095 1,997 1,504
Y / Y Investment Growth -14.96 % 0.94 % 4.87 % 32.81 % -28.13 %
Net Income in Millions -242 63 18 -86 -136
Y / Y Net Income Growth - 260.39 % - - -
Annual Return On Investment -13.49 % 2.99 % 0.84 % -4.32 % -9.03 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LIVN's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LIVN's Competitors
Subscribers only: Roi for Livanova Plc's Suppliers
Subscribers only: Return On Investment for LIVN's Customers

Other Ratios
LIVN's Roa LIVN's Inventory Turnover Ratio LIVN's Growth Rates LIVN's Dividend Statistics
LIVN's Profitability Ratios LIVN's Asset Turnover Ratio LIVN's Dividend Growth
LIVN's Roe LIVN's Valuation Ratios LIVN's Financial Strength Ratios LIVN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %

Date modified: 2026-11-07T13:22:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.